Projects per year
Abstract
SUMMARYThe ability to overcome metabolic stress is a major determinant of outcomes during infections. Pathogens face nutrient and oxygen deprivation in host niches and during their encounter with immune cells. Immune cells require metabolic adaptations for producing antimicrobial compounds and mounting antifungal inflammation. Infection also triggers systemic changes in organ metabolism and energy expenditure that range from an enhanced metabolism to produce energy for a robust immune response to reduced metabolism as infection progresses, which coincides with immune and organ dysfunction. Competition for energy and nutrients between hosts and pathogens means that successful survival and recovery from an infection require a balance between elimination of the pathogen by the immune systems (resistance), and doing so with minimal damage to host tissues and organs (tolerance). Here, we discuss our current knowledge of pathogen, immune cell and systemic metabolism in fungal infections, and the impact of metabolic disorders, such as obesity and diabetes. We put forward the idea that, while our knowledge of the use of metabolic regulation for fungal proliferation and antifungal immune responses (i.e., resistance) has been growing over the years, we also need to study the metabolic mechanisms that control tolerance of fungal pathogens. A comprehensive understanding of how to balance resistance and tolerance by metabolic interventions may provide insights into therapeutic strategies that could be used adjunctly with antifungal drugs to improve patient outcomes.
Original language | English |
---|---|
Article number | e0017122 |
Number of pages | 26 |
Journal | Microbiology and Molecular Biology Reviews |
Volume | 88 |
Issue number | 3 |
DOIs | |
Publication status | Published - Sept 2024 |
Keywords
- Aspergillus
- Candida
- Cryptococcus
- disease tolerance
- fungal infection
- fungal pathogens
- immunity
- immunometabolism
- metabolic disease
- metabolism
Projects
- 3 Finished
-
Immuno-metabolic interactions of the fungal superbug Candida auris
Traven, A. (Primary Chief Investigator (PCI)), Ben-Ami, R. (Chief Investigator (CI)), McConville, M. J. (Associate Investigator (AI)), Vince, J. E. (Associate Investigator (AI)) & Herold, M. (Associate Investigator (AI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/21 → 31/12/24
Project: Research
-
An investigation into metabolic competition between host and pathogen in infection.
Traven, A. (Primary Chief Investigator (PCI)), Naderer, T. (Associate Investigator (AI)), McConville, M. J. (Associate Investigator (AI)), Beilharz, T. (Associate Investigator (AI)) & Hickey, M. (Associate Investigator (AI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/19 → 31/12/22
Project: Research
-
An investigation into mitochondrial dynamics in the human pathogen Candida albicans
Traven, A. (Primary Chief Investigator (PCI)) & Lithgow, T. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/16 → 31/12/18
Project: Research